J30-8 is a potent and isoform-selective inhibitor of c-Jun N-terminal kinase 3 (JNK3) with an IC50 of 40 nM, which 2500-fold isoform selectivity against JNK1α1 and JNK2α2. J30-8 exhibits neuroprotective activity in vitro and potential for the treatment of neurodegenerative diseases.
Specifications & Purity: J30-8 is a potent and isoform-selective inhibitor of c-Jun N-terminal kinase 3 (JNK3) with an IC50 of 40 nM, which 2500-fold isoform selectivity against JNK1α1 and JNK2α2. J30-8 exhibits neuroprotective activity in vitro and potential for the treatment of neurodegenerative diseases.
Grade: Moligand™
Molecular Formula: C17H9ClFN3O2S
Molecular Weight: 373.79
PubChem CID: 4078145
Isomeric SMILES: C1=CC=C(C(=C1)NC2=NC(=C(S2)C3=C4C=C(C=CC4=NC3=O)F)O)Cl
Storage Temperature: Protected from light;Store at -20°C;Argon charged
Shipped in: Ice chest + Ice pads
- UPC:
- 41113641
- HazmatClass:
- Yes
- WeightUOM:
- LB
- MPN:
- J651095-1mg
- Country of Origin:
- China
- CAS:
- 2366255-71-0
- Product Size:
- 1mg
- Harmonized Tariff Code:
- 2931.90.90
akash.verma@cenmed.com
(732) 447-1115





